Insurmountable AT 1 receptor antagonism: the need for different antagonist binding states of the receptor

Author： Vauquelin G. Fierens F. Verheijen I. Vanderheyden P.

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.22, Iss.7, 2001-07, pp. : 343-344

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Insurmountable angiotensin AT 1 receptor antagonists: the role of tight antagonist binding

By Fierens F.L.P. Vanderheyden P.M.L. De Backer J.-P. Vauquelin G.

European Journal of Pharmacology, Vol. 372, Iss. 2, 1999-05 ,pp. : 199-206

Elsevier

Access to resources Recommend Favorite

Insurmountable AT 1 receptor antagonism: message in a model?

By Lew M. Christopoulos A. Ziogas J.

Trends in Pharmacological Sciences, Vol. 22, Iss. 11, 2001-11 ,pp. : 555-557

Elsevier

Access to resources Recommend Favorite

Insurmountable AT 1 receptor antagonism: fitting models with experimental data

By Vauquelin G. FierensIlse F. Vanderheyden V.

Trends in Pharmacological Sciences, Vol. 22, Iss. 11, 2001-11 ,pp. : 557-557

Elsevier

Access to resources Recommend Favorite

Effects of the insurmountable angiotensin AT 1 receptor antagonist candesartan and the surmountable antagonist losartan on ischemia/reperfusion injury in rat hearts

By Wang Q.-D. Sjoquist P.-O.

European Journal of Pharmacology, Vol. 380, Iss. 1, 1999-09 ,pp. : 13-21

Elsevier

Access to resources Recommend Favorite

Receptor binding profile of cyclazosin, a new 1B -adrenoceptor antagonist

By Giardina D. Crucianelli M. Melchiorre C. Taddei C. Testa R.

European Journal of Pharmacology, Vol. 287, Iss. 1, 1995-12 ,pp. : 13-16

Elsevier

Access to resources Recommend Favorite